CAT Act of 2024

Bill 118 hr 10006 aims to make changes to title XVIII of the Social Security Act in order to enhance transparency when it comes to suspending Medicare payments during an investigation into allegations of fraud. The bill seeks to ensure that the process of suspending payments is fair and efficient, while also protecting the rights of healthcare providers.

Under the proposed legislation, the Centers for Medicare & Medicaid Services (CMS) would be required to provide detailed information to healthcare providers when suspending Medicare payments due to a credible allegation of fraud. This information would include the specific reasons for the suspension, as well as the evidence supporting the allegation.

Additionally, the bill would establish a process for healthcare providers to appeal a suspension of Medicare payments. This process would allow providers to challenge the suspension and present evidence in their defense. The goal is to ensure that providers are given a fair opportunity to address any allegations of fraud before their payments are suspended. Overall, Bill 118 hr 10006 seeks to improve transparency and due process in the suspension of Medicare payments during fraud investigations. By providing healthcare providers with more information and a formal appeals process, the bill aims to protect the rights of providers while also safeguarding the integrity of the Medicare program.